Hyperoxia-derived lung damage in preterm infants

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 4, 2010, Pages 223-229

  Bhandari, Vineet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Cytokines; Oxidants; Oxygen; Pulmonary

Indexed keywords

BOMBESIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL DEATH; CYTOKINE PRODUCTION; HUMAN; HYPEROXIA; INFLAMMATION; INFLAMMATORY CELL; LUNG EDEMA; LUNG INJURY; NONHUMAN; OXYGEN TOXICITY; PATHOGENESIS; PREMATURITY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFANT, PREMATURE; LUNG INJURY;

EID: 77955055436     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2010.03.009     Document Type: Article

References (60)

1. Warner B.B., Stuart L.A., Papes R.A., Wispe J.R. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998, 275:L110-L117.
2. Horowitz S. Pathways to cell death in hyperoxia. Chest 1999, 116:64S-67S.
3. O'Reilly M.A. DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol 2001, 281:L291-L305.
4. Thickett D.R., Armstrong L., Christie S.J., Millar A.B. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164:1601-1605.
5. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 1986, 48:721-731.
6. Ben-Ari J., Makhoul I.R., Dorio R.J., Buckley S., Warburton D., Walker S.M. Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2000, 2:365-369.
7. O'Reilly M.A., Marr S.H., Yee M., McGrath-Morrow S.A., Lawrence B.P. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 2008, 177:1103-1110.
8. Yee M., Chess P.R., McGrath-Morrow S.A., et al. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 2009, 297:L641-L649.
9. Johnston C.J., Wright T.W., Reed C.K., Finkelstein J.N. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res 1997, 23:537-552.
10. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991, 11:463-494.
11. Coalson J.J., Winter V.T., Siler-Khodr T., Yoder B.A. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999, 160:1333-1346.
12. Bhandari V., Elias J.A. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 2006, 41:4-18.
13. Barazzone C., White C.W. Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins. Am J Respir Cell Mol Biol 2000, 22:517-519.
14. Pagano A., Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann NY Acad Sci 2003, 1010:405-416.
15. Bustani P., Kotecha S. Role of cytokines in hyperoxia mediated inflammation in the developing lung. Front Biosci 2003, 8:s694-s704.
16. Mantell L.L., Horowitz S., Davis J.M., Kazzaz J.A. Hyperoxia-induced cell death in the lung - the correlation of apoptosis, necrosis, and inflammation. Ann NY Acad Sci 1999, 887:171-180.
17. Thiel M., Chouker A., Ohta A., et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 2005, 3:e174.
18. Vozzelli M.A., Mason S.N., Whorton M.H., Auten R.L. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2004, 286:L488-L493.
19. Boyce N.W., Campbell D., Holdsworth S.R. Granulocyte independence of pulmonary oxygen toxicity in the rat. Exp Lung Res 1989, 15:491-498.
20. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., Mignotte B. The biochemistry of programmed cell death. Faseb J 1995, 9:1277-1287.
21. Ward N.S., Waxman A.B., Homer R.J., et al. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000, 22:535-542.
22. Joza N., Kroemer G., Penninger J.M. Genetic analysis of the mammalian cell death machinery. Trends Genet 2002, 18:142-149.
23. O'Reilly M.A., Staversky R.J., Huyck H.L., et al. Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest 2000, 80:1845-1854.
24. Wang X., Ryter S.W., Dai C., et al. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 2003, 278:29184-29191.
25. Henson P.M. Dampening inflammation. Nat Immunol 2005, 6:1179-1181.
26. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197.
27. Thomson A., Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomarker Insights 2008, 3:361-373.
28. Bhandari A., Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009, 123:1562-1573.
29. Subramaniam M., Bausch C., Twomey A., et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007, 176:902-912.
30. Sunday M.E., Yoder B.A., Cuttitta F., Haley K.J., Emanuel R.L. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 1998, 102:584-594.
31. Cullen A., Van Marter L.J., Allred E.N., Moore M., Parad R.B., Sunday M.E. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002, 165:1093-1097.
32. Padela S., Cabacungan J., Shek S., et al. Hepatocyte growth factor is required for alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2005, 172:907-914.
33. Ohki Y., Mayuzumi H., Tokuyama K., et al. Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia. Neonatology 2009, 95:332-338.
34. Lassus P., Heikkila P., Andersson L.C., von Boguslawski K., Andersson S. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants. J Pediatr 2003, 143:199-202.
35. D'Angio C.T., LoMonaco M.B., Chaudhry S.A., Paxhia A., Ryan R.M. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp Lung Res 1999, 25:443-465.
36. Bry K., Whitsett J.A., Lappalainen U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 2007, 36:32-42.
37. Choo-Wing R., Nedrelow J.H., Homer R.J., Elias J.A., Bhandari V. Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2007, 293:L142-L150.
38. Lindsay L., Oliver S.J., Freeman S.L., Josien R., Krauss A., Kaplan G. Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation 2000, 24:347-356.
39. Wagenaar G.T., ter Horst S.A., van Gastelen M.A., et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med 2004, 36:782-801.
40. Deng H., Mason S.N., Auten R.L. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000, 162:2316-2323.
41. Auten R.L., Mason S.N., Tanaka D.T., Welty-Wolf K., Whorton M.H. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 2001, 281:L336-L344.
42. Frank L. Protective effect of keratinocyte growth factor against lung abnormahlities associated with hyperoxia in prematurely born rats. Biol Neonate 2003, 83:263-272.
43. Franco-Montoya M.L., Bourbon J.R., Durrmeyer X., Lorotte S., Jarreau P.H., Delacourt C. Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2009, 297:L965-76.
44. Danan C., Franco M.L., Jarreau P.H., et al. High concentrations of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002, 165:1384-1387.
45. Baier J., Majid A., Parupia H., Loggins J., Kruger T. CC chemokine concentrations, increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004, 37:137-148.
46. Radomski A., Sawicki G., Olson D.M., Radomski M.W. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 1998, 125:1455-1462.
47. Hosford G.E., Fang X., Olson D.M. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization. Pediatr Res 2004, 56:26-34.
48. Tambunting F., Beharry K.D., Hartleroad J., Waltzman J., Stavitsky Y., Modanlou H.D. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol 2005, 39:5-14.
49. Chetty A., Cao G.J., Severgnini M., Simon A., Warburton R., Nielsen H.C. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol 2008, 295:L584-L592.
50. Lukkarinen H., Hogmalm A., Lappalainen U., Bry K. Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2009, 41:59-68.
51. Cederqvist K., Sorsa T., Tervahartiala T., et al. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001, 108:686-692.
52. Sweet D.G., Curley A.E., Chesshyre E., et al. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr 2004, 93:791-796.
53. Dasgupta C., Sakurai R., Wang Y., et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 2009, 296:L1031-L1041.
54. Alejandre-Alcazar M.A., Kwapiszewska G., Reiss I., et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007, 292:L537-L549.
55. Nakanishi H., Sugiura T., Streisand J.B., Lonning S.M., Roberts J.D. TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 2007, 293:L151-L161.
56. Gauldie J., Galt T., Bonniaud P., Robbins C., Kelly M., Warburton D. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 2003, 163:2575-2584.
57. Vicencio A.G., Lee C.G., Cho S.J., et al. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?. Am J Respir Cell Mol Biol 2004, 31:650-656.
58. D'Angio C.T., Maniscalco W.M. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci 2002, 7:d1609-d1623.
59. Bhandari V., Choo-Wing R., Lee C.G., et al. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 2008, 39:420-430.
60. Mura M., dos Santos C.C., Stewart D., Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 2004, 97:1605-1617.